T helper type 2 bias and type 17 suppression in primary dengue virus infection in infants and young children

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 107, Issue 7, 2013, Pages 411-419

  Talarico, Laura B ^a   Bugna, Jimena ^a   Wimmenauer, Vera ^a   Espinoza, Marco A ^b   Quipildor, Marcelo O ^b   Hijano, Diego R ^a,c   Beccaria, Martin ^a   Wurster, Victoria ^a,c   Cavagnaro, Luis E ^d   Martinez, Daniel ^d   Fattore, Gladys ^e   Batalle, Juan P ^a   Acosta, Patricio L ^a   Reynoso, Natalia ^a   Melendi, Guillermina A ^a,c   Rey, Felix A ^f   Libster, Romina ^a,c   Polack, Fernando P ^a,c  

^a Ciudad Autónoma de Buenos Aires   (Argentina)

^b Hospital San Vicente de Paul   (Argentina)

^c VANDERBILT UNIVERSITY   (United States)

^d Hospital SAMIC Iguazu   (Argentina)

^e Fundacion Mundo Sano ^*  (Argentina)

^f INSTITUT PASTEUR   (France)

Author keywords

Dengue virus; Immune immaturity; Infant; Th2 polarization

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 4;

ADAPTIVE IMMUNITY; ANIMAL CELL; ARTICLE; CHILD; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENGUE; DENGUE VIRUS 1; FEMALE; FEVER; HUMAN; HUMAN CELL; INFANT; INFLAMMATION; MALE; MEMORY CELL; MOTHER; NEWBORN; NONHUMAN; PRESCHOOL CHILD; TH1 CELL; TH17 CELL; TH2 CELL; VIRUS IMMUNITY;

DENGUE VIRUS; IMMUNE IMMATURITY; INFANT; TH2 POLARIZATION;

ADULT; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ARGENTINA; CHILD, PRESCHOOL; CYTOKINES; DENGUE; DENGUE VIRUS; EPIDEMICS; FEMALE; HUMANS; IMMUNITY, CELLULAR; IMMUNOGLOBULIN G; INFANT; INFANT, NEWBORN; INTERLEUKIN-17; MALE; T-LYMPHOCYTES, HELPER-INDUCER; TH2 CELLS;

EID: 84889025121     PISSN: 00359203     EISSN: 18783503     Source Type: Journal    
DOI: 10.1093/trstmh/trt044     Document Type: Article

References (32)

1. Gubler DJ. Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol 2002;10:100-3.
2. Kalayanarooj S, Vaughn DW, Nimmannitya S et al. Early clinical and laboratory indicators of acute dengue illness. J Infect Dis 1997;176:313-21.
3. Kittigul L, Pitakarnjanakul P, Sujirarat D et al. The differences of clinical manifestations and laboratory findings in children and adults with dengue virus infection. J Clin Virol 2007;39:76-81.
4. Chau TN, Quyen NT, Thuy TT et al. Dengue in Vietnamese infants-results of infection-enhancement assays correlate with age-related disease epidemiology, and cellular immune responses correlate with disease severity. J Infect Dis 2008;198:516-24.
5. Halstead SB, Lan NT, Myint TT, et al. Denguehemorrhagic fever in infants: research opportunities ignored. Emerg Infect Dis 2002;8:1474-9.
6. Kliks SC, Nimmanitya S, Nisalak A et al. Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Am J Trop Med Hyg 1988;38:411-9.
7. Dirección de Epidemiología, sala de situación de salud (año 2009). Ministerio de Salud de la Nación Argentina.
8. Munoz FM. Influenza virus infection in infancy and early childhood. Paediatr Respir Rev 2003;4:99-104.
9. Tregoning JS, Schwarze J. Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology. Clin Microbiol Rev 2010;23:74-98.
10. Roux X, Remot A, Petit-Camurdan A et al. Neonatal lung immune responses show a shift of cytokines and transcription factors toward Th2 and a deficit in conventional and plasmacytoid dendritic cells. Eur J Immunol 2011;41:2852-61.
11. Duangchinda T, Dejnirattisai W, Vasanawathana S et al. Immunodominant T-cell responses to dengue virus NS3 are associated with DHF. Proc Natl Acad Sci U S A 2010;107:16922-7.
12. Mongkolsapaya J, DejnirattisaiW, Xu XN et al. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat Med 2003;9:921-7.
13. Lanciotti RS, Calisher CH, Gubler DJ et al. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptasepolymerase chain reaction. J Clin Microbiol 1992;30:545-51.
14. Balmaseda A, Standish K, Mercado JC, et al. Trends in patterns of dengue transmission over 4 years in a pediatric cohort study in Nicaragua. J Infect Dis 2010;201:5-14.
15. Cockburn JJ, Navarro Sanchez ME, Fretes N et al. Mechanism of dengue virus broad cross-neutralization by a monoclonal antibody. Structure 2012;20:303-14.
16. Cockburn JJ, NavarroSanchez ME, Goncalvez AP, et al. Structural insights into the neutralizationmechanismofahigherprimate antibodyagainst dengue virus. EMBO J 2012;31:767-79.
17. Bugna J, Moreno J, Sanchez S et al. Fever and bleeding in a newborn baby. Pediatr Infect Dis J 2010;29:1153-8.
18. van de Veerdonk FL, Gresnigt MS, Kullberg BJ, et al. Th17 responses and host defense against microorganisms: an overview. BMB Rep 2009;42:776-87.
19. Miossec P, Korn T, Kuchroo VK. Interleukin-17 and type 17 helper Tcells. N Engl J Med 2009;361:888-98.
20. Sierra B, Perez AB, Vogt K et al. Secondary heterologous dengue infection risk: Disequilibrium between immune regulation and inflammation? Cell Immunol 2010;262:134-40.
21. Chaturvedi UC. Shift to Th2 cytokine response in dengue haemorrhagic fever. Indian J Med Res 2009;129:1-3.
22. ChenRF, LiuJW, Yeh WTet al. AlteredT helper1reaction but not increase of virus load in patients with denguehemorrhagic fever. FEMSImmunol Med Microbiol 2005;44:43-50.
23. Halstead SB, Mahalingam S, Marovich MA et al. Intrinsic antibodydependent enhancement of microbial infection in macrophages: disease regulation by immune complexes. Lancet Infect Dis 2010;10:712-22.
24. Pacsa AS, Agarwal R, Elbishbishi EA et al. Role of interleukin-12 in patients with dengue hemorrhagic fever. FEMS Immunol Med Microbiol 2000;28:151-5.
25. Yang KD, Yeh WT, Yang MY et al. Antibody-dependent enhancement of heterotypic dengue infections involved in suppression of IFNgamma production. J Med Virol 2001;63:150-7.
26. Halstead SB. Dengue. Lancet 2007;370:1644-52.
27. Delgado MF, Coviello S, Monsalvo AC et al. Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease. Nat Med 2009;15:34-41.
28. Polack FP, Auwaerter PG, Lee SH et al. Production of atypical measles in rhesus macaques: evidence for disease mediated by immune complex formationandeosinophils in the presence of fusion-inhibiting antibody. Nat Med 1999;5:629-34.
29. Garcia C, Soriano-Fallas A, Lozano J et al. Decreased innate immune cytokine responses correlate with disease severity in children with respiratory syncytial virus and human rhinovirus bronchiolitis. Pediatr Infect Dis J 2011;vol no,pp-pp.
30. Ma J, Dushoff J, Earn DJ. Age-specific mortality risk from pandemic influenza. J Theor Biol 2011;288:29-34.
31. Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ et al. Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med 2000;342:635-45.
32. Gomersall CD, Joynt GM, Lam P et al. Short-term outcome of critically ill patients with severe acute respiratory syndrome. Intensive Care Med 2004;30:381-7.